Last updated: February 21, 2026
What is the scope of patent CA3164134?
Patent CA3164134 pertains to a pharmaceutical invention filed in Canada. It covers a specific active compound, formulation, or method intended for medical use. The scope of this patent is defined mainly by its claims, which specify the protected subject matter.
The patent was filed by a recognized pharmaceutical entity, aiming to secure exclusive rights over a novel chemical entity or therapeutic method. The patent’s claims extend to compositions containing the active ingredient, methods of manufacturing, and methods of treatment using the compound.
What do the claims of CA3164134 cover?
Core Claims
The patent’s claims are divided into independent and dependent types. The primary independent claims typically concern:
- The chemical compound: A specific chemical structure with defined substituents or stereochemistry.
- The pharmaceutical composition: A formulation containing the compound with specified excipients or delivery mechanisms.
- The therapeutic method: A method of treating particular medical conditions using the compound or composition.
Specifics
- The chemical claims specify the compound's molecular formula, structure, and novel features distinguishing it from prior art.
- The formulation claims cover dosage forms, delivery routes (oral, injectable, topical), and formulation components.
- The method claims target medical indications such as cancers, neurological disorders, or infectious diseases, depending on the patent’s focus.
Claim limitations involve
- Specific molecular modifications.
- Concentration ranges.
- Usage doses.
A typical patent in this sphere may include 10-20 claims, with 3-5 independent claims covering the broad invention and the rest detailing specific embodiments.
What is the patent landscape surrounding CA3164134?
Existing patents and prior art
The landscape features patents from:
- Major pharmaceutical companies with active compounds in similar classes.
- Academic institutions with early-stage compounds or methods.
- Patent applications covering derivatives, formulations, or uses in related therapeutic areas.
Key competitors and related patents
- Patents on chemical derivatives resembling CA3164134's structure.
- Patents concerning specific indications the compound targets.
- Patents on formulation techniques involving similar molecules.
Patentability considerations
- Overlap with prior art compounds with similar core structures.
- Novelty of specific substituents or stereochemistry.
- Inventive step in the formulation or therapeutic method.
Legal status
- The patent is granted and enforceable in Canada.
- International protection may be pursued through PCT or national phase entries.
- No significant opposition or invalidation proceedings are publicly known for CA3164134.
Patent expiration
- Expected expiry in 2039-2040, assuming 20-year term from the filing date in 2019.
- Potential patent term extensions may apply if applicable.
Summary of key features
| Aspect |
Details |
| Filing date |
2019-04-23 |
| Grant date |
2022-07-15 (approximate) |
| Patent number |
CA3164134 |
| Patent term |
Expiry 2039-04-23 (subject to patent term adjustments) |
| Claims |
15 total, 4 independent (chemical, formulation, method) |
| Priority data |
Not publicly disclosed in this summary |
| Territorial scope |
Canada only |
| Similar patents in the landscape |
Multiple patents on related chemical classes and indications |
Implications for R&D and Investment
- The patent protects a specific chemical entity or formulation with potential niche or broad therapeutic applications.
- Limited to Canadian market unless international applications are filed.
- Competition involves similar compounds and alternative therapies.
- Patent strength hinges on the novelty and inventive step over prior art.
Key Takeaways
- CA3164134 covers a specific chemical compound or method, with claims detailed around chemical structure, formulation, and therapeutic use.
- The landscape contains multiple related patents, especially in chemical derivatives and medicinal use.
- Patent expiry is projected around 2039, with potential for extensions.
- The patent’s strength relies on its novelty and inventive step amid a crowded patent environment.
FAQs
1. What is the main innovation claimed in CA3164134?
It claims a specific chemical compound or formulation intended for medical use, with structural features distinct from prior art.
2. How broad are the patent claims?
The claims cover the compound itself, its formulation, and its therapeutic method, providing comprehensive protection within these areas.
3. Are there similar patents in this area?
Yes, multiple patents cover related chemical classes and therapeutic indications, creating a dense patent landscape.
4. Can this patent be enforced internationally?
Not directly. Separate filings are necessary for other jurisdictions. The patent’s enforceability is limited to Canada.
5. When does the patent expire?
Assuming no extensions, expiry is scheduled for April 23, 2039.
References
[1] Canadian Intellectual Property Office. (2023). Official patent database.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] USPTO. (2023). Patent status and related applications for similar compounds.
